WELL Health Technologies Corp T.WELL

comparable U.S. digital health stock - HIMS on NYSE

[speedy99]

"The stock is dirt cheap

There is evidence that Hims & Hers is one of the cheapest stocks on the market today. It trades at a small market cap of just $1.4 billion. Using management's revenue guidance of $255 million, that works out to a price-to-sales ratio of 5.9.""



See comment above from analyst.  If they like HIMS at a 1.4 billion valuation and revenue guidance of $255 million, I imagine they will love WELL when it gets listed in the States, with a guidance of $400 million revenue, and the same 1.4 billion valuation.  

[HotDiggityDogg]

I also agree that WELL is extremely cheap but HIMS has a very impressive gross margin. I hope that WELL can be valuated with the same multiple but given the Clinics part of the WELL business, and the lower margins of that part of the business, it will be hard to compare WELL to HIMS. Having said that, the current valuation by most analysts for WELL which sits at $12-15 is in my mind accurate and